Paul Gray Parker - 30 Sep 2022 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role: Director
Signature: By Cheryl Brice, Attorney-in-Fact for
Issuer symbol: CLX
Transactions as of: 30 Sep 2022
Net transactions value: +$7,703
Form type: 4
Filing time: 04 Oct 2022, 16:23:40 UTC
Previous filing: 05 Jul 2022
Next filing: 04 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLX	Common Stock	Award	$7,703	+60	+24%	$128.39	311	30 Sep 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLX	Deferred Stock Units	Award	$0	+8	+0.81%	$0.000000	940	12 Aug 2022	Common Stock	8		Direct	F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Receipt of Common Stock in lieu of portion of quarterly director's fee.
F2	1-for-1
F3	Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F4	The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.